Otic capsule dehiscence (OCD) encompasses a spectrum of third mobile window disorders, including type II variants characterized by a direct interface between the membranous labyrinth and adjacent vascular structures. These labyrinthine-vascular dehiscences (type IIa: superior semicircular canal-superior petrosal sinus (SPS); type IIb: internal jugular vein-vestibular structures) may induce pulsatile tinnitus,...
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for most audiologists; this describes a novel surgical/endovascular technique for a rare, surgically managed condition — relevant primarily to neurotologists and interventional radiologists, not to hearing-aid fitting or standard audiology practice.
Expanding the therapeutic toolkit for third mobile window disorders beyond conventional open surgery could improve outcomes for a rare but debilitating subset of inner-ear patients.
- 01Type II labyrintho-vascular otic capsule dehiscence is a rare third mobile window disorder distinct from superior canal dehiscence.
- 02An endovascular (inside-the-blood-vessel) treatment approach is proposed as an alternative to open surgical repair.
- 03Published in European Annals of Otorhinolaryngology, Head and Neck Diseases.
- 04The approach targets the vascular component unique to this dehiscence subtype.
- 05Case-level evidence; not yet validated in large controlled studies.
Endovascular management is a viable therapeutic approach for type II labyrintho-vascular otic capsule dehiscence.
studypartially supportedType II labyrintho-vascular otic capsule dehiscence is a third mobile window disorder distinct from superior canal dehiscence.
studysupported- PMID
- 42855334
- DOI
- 10.1016/j.anorl.2026.07.013.
- Journal
- European Annals of Otorhinolaryngology, Head and Neck Diseases
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with type II labyrintho-vascular otic capsule dehiscence
- Intervention
- Endovascular management of otic capsule dehiscence
Primary outcomes
Feasibility and outcomes of endovascular treatment for type II otic capsule dehiscence